4D Molecular Therapeutics, Inc.FDMTNASDAQ
LOADING
|||
Switch Symbol:
EPS Growth Accelerating
Trending higher, above historical average.
Left:
||||
Year-over-year earnings per share growth rate
Latest
-3.06%
↑ 84% above average
Average (30q)
-19.00%
Historical baseline
Range
High:68.83%
Low:-274.42%
Volatility
-1806.9%
Relatively stable
| Period | Value |
|---|---|
| Q3 2025 | -3.06% |
| Q2 2025 | -13.95% |
| Q1 2025 | 4.44% |
| Q4 2024 | -13.92% |
| Q3 2024 | -25.40% |
| Q2 2024 | 4.55% |
| Q1 2024 | 20.48% |
| Q4 2023 | -245.83% |
| Q3 2023 | 68.83% |
| Q2 2023 | 7.23% |
| Q1 2023 | 1.19% |
| Q4 2022 | -13.51% |
| Q3 2022 | 12.94% |
| Q2 2022 | -4.94% |
| Q1 2022 | 12.90% |
| Q4 2021 | -13.41% |
| Q3 2021 | -192.86% |
| Q2 2021 | 54.10% |
| Q1 2021 | 20.78% |
| Q4 2020 | -113.89% |
| Q3 2020 | 64.71% |
| Q2 2020 | -14.61% |
| Q1 2020 | 18.35% |
| Q4 2019 | 2.68% |
| Q3 2019 | 30.43% |
| Q2 2019 | 0.00% |
| Q1 2019 | -274.42% |
| Q4 2018 | 0.00% |
| Q3 2018 | 17.31% |
| Q2 2018 | 0.00% |
| Q1 2018 | 0.00% |